Cohero Health Secures $2M Seed Investment

Creator of innovative respiratory disease management platform closes seed round, led by Blue Cross Blue Shield of Massachusetts’ Zaffre Investments.

NEW YORK, NY
December 15, 2015
Cohero Health, a digital health company focused on developing connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices, has announced that they closed a seed investment round of 2 million dollars. Key investors include Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts, Three Leaf Ventures an affiliate of the Broe Group, Bioadvance and Swanhill Capital. StartUp Health, of which Cohero Health is a member, also participated via their digital health syndicate on AngelList. Cohero Health’s connected devices and mobile applications active engage and empower respiratory patients by measuring lung function and tracking adherence. The company’s proprietary platform comprises wireless medication inhaler sensors to track patient adherence, an FDA cleared mobile spirometer to measure lung function, mobile applications to engage patients, generate custom reminders and reward compliance, and access to custom data via HIPAA-compliant servers to support robust patient monitoring.

Cohero Health is the first and only company to enable tracking of controller medication, rescue medication and discern lung function in real-time, in an integrated comprehensive model. The company is poised to transform care of asthma and COPD patients through improved self management, and by empowering clinicians with critical components of optimal respiratory care, knowing how patients are using their medication  and how they are responding.

Read the rest of the story here.